- Home
- FLNA vs EEA Comparison
FLNA vs EEA Comparison
Compare FLNA & EEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FLNA | EEA |
|---|---|---|
| Founded | 1998 | 1986 |
| Country | United States | Germany |
| Employees | 20 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 73.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FLNA | EEA |
|---|---|---|
| Price | $0.89 | $10.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 368.3K | 30.2K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.92% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.90 | $9.62 |
| 52 Week High | $2.03 | $11.43 |
Technical Indicators
Market Signals| Indicator | FLNA | EEA |
|---|---|---|
| Relative Strength Index (RSI) | 23.58 | 49.55 |
| Support Level | N/A | $10.57 |
| Resistance Level | $1.80 | $11.07 |
| Average True Range (ATR) | 0.07 | 0.19 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 2.43 | 27.93 |
Price Performance
Historical ComparisonAbout FLNA Filana Therapeutics Inc. Common Stock
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.